These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 30462197)

  • 1. Suppression of Prolactin Secretion Partially Explains the Antidiabetic Effect of Bromocriptine in ob/ob Mice.
    Furigo IC; Suzuki MF; Oliveira JE; Ramos-Lobo AM; Teixeira PDS; Pedroso JA; de Alencar A; Zampieri TT; Buonfiglio DC; Quaresma PGF; Prada PO; Bartolini P; Soares CRJ; Donato J
    Endocrinology; 2019 Jan; 160(1):193-204. PubMed ID: 30462197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-Aminoimidazole-4-carboxamide ribonucleoside treatment improves glucose homeostasis in insulin-resistant diabetic (ob/ob) mice.
    Song XM; Fiedler M; Galuska D; Ryder JW; Fernström M; Chibalin AV; Wallberg-Henriksson H; Zierath JR
    Diabetologia; 2002 Jan; 45(1):56-65. PubMed ID: 11845224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central prolactin modulates insulin sensitivity and insulin secretion in diabetic rats.
    Park S; Kang S; Lee HW; Ko BS
    Neuroendocrinology; 2012; 95(4):332-43. PubMed ID: 22441304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidiabetic effect of a novel non-thiazolidinedione PPAR gamma/alpha agonist on ob/ob mice.
    Hu X; Feng Y; Shen Y; Zhao XF; Yu JH; Yang YS; Leng Y
    Acta Pharmacol Sin; 2006 Oct; 27(10):1346-52. PubMed ID: 17007742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoglycemic effects of MDG-1, a polysaccharide derived from Ophiopogon japonicas, in the ob/ob mouse model of type 2 diabetes mellitus.
    Xu J; Wang Y; Xu DS; Ruan KF; Feng Y; Wang S
    Int J Biol Macromol; 2011 Nov; 49(4):657-62. PubMed ID: 21756932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased responsiveness to the hyperglycemic, hyperglucagonemic and hyperinsulinemic effects of circulating norepinephrine in ob/ob mice.
    Liang Y; Cincotta AH
    Int J Obes Relat Metab Disord; 2001 May; 25(5):698-704. PubMed ID: 11360153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolactin regulatory element-binding (PREB) protein regulates hepatic glucose homeostasis.
    Park JM; Kim MY; Kim TH; Min DK; Yang GE; Ahn YH
    Biochim Biophys Acta Mol Basis Dis; 2018 Jun; 1864(6 Pt A):2097-2107. PubMed ID: 29601978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel extract of Gymnema sylvestre improves glucose tolerance in vivo and stimulates insulin secretion and synthesis in vitro.
    Al-Romaiyan A; King AJ; Persaud SJ; Jones PM
    Phytother Res; 2013 Jul; 27(7):1006-11. PubMed ID: 22911568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of prolonged bromocriptine administration on PRL secretion GH and glycaemic control in stable insulin-dependent diabetes mellitus.
    Scobie IN; Kesson CM; Ratcliffe JG; Maccuish AC
    Clin Endocrinol (Oxf); 1983 Feb; 18(2):179-85. PubMed ID: 6342861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [D-LEU-4]-OB3, a synthetic leptin agonist, improves hyperglycemic control in C57BL/6J ob/ob mice.
    Grasso P; Rozhavskaya-Arena M; Leinung MC; Lee DW
    Regul Pept; 2001 Sep; 101(1-3):123-9. PubMed ID: 11495687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term administration of estradiol decreases expression of hepatic lipogenic genes and improves insulin sensitivity in ob/ob mice: a possible mechanism is through direct regulation of signal transducer and activator of transcription 3.
    Gao H; Bryzgalova G; Hedman E; Khan A; Efendic S; Gustafsson JA; Dahlman-Wright K
    Mol Endocrinol; 2006 Jun; 20(6):1287-99. PubMed ID: 16627594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bromocriptine mesylate improves glucose tolerance and disposal in a high-fat-fed canine model.
    Moore MC; Smith MS; Swift LL; Cincotta AH; Ezrokhi M; Cominos N; Zhang Y; Farmer B; Cherrington AD
    Am J Physiol Endocrinol Metab; 2020 Jul; 319(1):E133-E145. PubMed ID: 32459527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihyperglycaemic effect of saccharin in diabetic ob/ob mice.
    Bailey CJ; Day C; Knapper JM; Turner SL; Flatt PR
    Br J Pharmacol; 1997 Jan; 120(1):74-8. PubMed ID: 9117102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bromocriptine improves glucose tolerance independent of circadian timing, prolactin, or the melanocortin-4 receptor.
    Framnes-DeBoer SN; Bakke E; Yalamanchili S; Peterson H; Sandoval DA; Seeley RJ; Arble DM
    Am J Physiol Endocrinol Metab; 2020 Jan; 318(1):E62-E71. PubMed ID: 31794265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel glucagon-like peptide-1 (GLP-1) analog (Val8)GLP-1 results in significant improvements of glucose tolerance and pancreatic beta-cell function after 3-week daily administration in obese diabetic (ob/ob) mice.
    Green BD; Lavery KS; Irwin N; O'harte FP; Harriott P; Greer B; Bailey CJ; Flatt PR
    J Pharmacol Exp Ther; 2006 Aug; 318(2):914-21. PubMed ID: 16648370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment with a novel agent combining docosahexaenoate and metformin increases protectin DX and IL-6 production in skeletal muscle and reduces insulin resistance in obese diabetic db/db mice.
    Mitchell PL; Nachbar R; Lachance D; St-Pierre P; Trottier J; Barbier O; Marette A
    Diabetes Obes Metab; 2017 Mar; 19(3):313-319. PubMed ID: 27800648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolactin protects against diabetes induced by multiple low doses of streptozotocin in mice.
    Holstad M; Sandler S
    J Endocrinol; 1999 Nov; 163(2):229-34. PubMed ID: 10556772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of new oral antidiabetic agent CS-045. Studies in KK and ob/ob mice and Zucker fatty rats.
    Fujiwara T; Yoshioka S; Yoshioka T; Ushiyama I; Horikoshi H
    Diabetes; 1988 Nov; 37(11):1549-58. PubMed ID: 3053303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antidiabetic effects of the Cimicifuga racemosa extract Ze 450 in vitro and in vivo in ob/ob mice.
    Moser C; Vickers SP; Brammer R; Cheetham SC; Drewe J
    Phytomedicine; 2014 Sep; 21(11):1382-9. PubMed ID: 25022210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (-)-BM 13.0913: a new oral antidiabetic agent that improves insulin sensitivity in animal models of type II (non-insulin-dependent) diabetes mellitus.
    Freund P; Wolff HP; Kühnle HF
    Metabolism; 1995 May; 44(5):570-6. PubMed ID: 7752903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.